http://orcid.org/0000-0002-3426-1044
References
- Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372:1589–1597.
- Chandrasekharan S, Minear MA, Hung A, et al. Noninvasive prenatal testing goes global. Sci Transl Med. 2014;6:231fs15.
- Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med. 2011;13:913–920.
- Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med. 2012;14:296–305.
- Jensen TJ, Zwiefelhofer T, Tim RC, et al. High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma. PLOS One. 2013;8:e57381.
- Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012;207:137.e1–137.e8.
- Taylor-Phillips S, Freeman K, Geppert J, et al. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open. 2016;6:e010002.
- American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol. 2012;120:1532–1534.
- Devers PL, Cronister A, Ormond KE, et al. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Counsel. 2013;22:291–295.
- Benn P, Borrell A, Cuckle H, et al. Prenatal detection of Down syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. Prenat Diagn. 2012;32:1–2.
- Benn P, Curnow KJ, Chapman S, et al. An economic analysis of cell-free DNA non-invasive prenatal testing in the US general pregnancy population. PLOS One. 2015;10:e0132313.
- Suskin E, Hercher L, Aaron KE, et al. The integration of noninvasive prenatal screening into the existing prenatal paradigm: a survey of current genetic counseling practice. J Genet Counsel. 2016;25:1032–1043.
- Chiu RWK, Chan KCA, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA. 2008;105:20458–20463.
- Fan HC, Quake SR. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLOS One. 2010;5:e10439.
- Chandrananda D, Thorne NP, Ganesamoorthy D, et al. Investigating and correcting plasma DNA sequencing coverage bias to enhance aneuploidy discovery. PLOS One. 2014;9:e86993.
- Lo KK, Boustred C, Chitty LS, et al. RAPIDR: an analysis package for non-invasive prenatal testing of aneuploidy. Bioinformatics. 2014;30:2965–2967.
- Johansson LF, de Boer EN, de Weerd HA, et al. Novel algorithms for improved sensitivity in non-invasive prenatal testing. Sci Rep. 2017;7:1838.
- Straver R, Sistermans EA, Holstege H, et al. WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. Nucleic Acids Res. 2014;42:e31.
- Sun K, Chan KC, Hudecova I, et al. COFFEE: control-free noninvasive fetal chromosomal examination using maternal plasma DNA. Prenat Diagn. 2017;37:336–340.
- Yu SCY, Chan KCA, Zheng YWL, et al. Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. Proc Natl Acad Sci USA. 2014;111:8583–8588.